[go: up one dir, main page]

GB9800750D0 - Pharmaceutical compound - Google Patents

Pharmaceutical compound

Info

Publication number
GB9800750D0
GB9800750D0 GBGB9800750.3A GB9800750A GB9800750D0 GB 9800750 D0 GB9800750 D0 GB 9800750D0 GB 9800750 A GB9800750 A GB 9800750A GB 9800750 D0 GB9800750 D0 GB 9800750D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compound
pharmaceutical
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9800750.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co Ltd
Eli Lilly and Co
Original Assignee
Eli Lilly and Co Ltd
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co Ltd, Eli Lilly and Co filed Critical Eli Lilly and Co Ltd
Priority to GBGB9800750.3A priority Critical patent/GB9800750D0/en
Publication of GB9800750D0 publication Critical patent/GB9800750D0/en
Priority to JP2000540115A priority patent/JP2002509135A/ja
Priority to CA002317536A priority patent/CA2317536A1/fr
Priority to AU21728/99A priority patent/AU2172899A/en
Priority to EP99901722A priority patent/EP1047670A1/fr
Priority to PCT/GB1999/000099 priority patent/WO1999036398A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB9800750.3A 1998-01-14 1998-01-14 Pharmaceutical compound Ceased GB9800750D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9800750.3A GB9800750D0 (en) 1998-01-14 1998-01-14 Pharmaceutical compound
JP2000540115A JP2002509135A (ja) 1998-01-14 1999-01-13 神経細胞カルシウムチャンネルの活性の調節剤としてのアミノスルホニルベンズアミド誘導体
CA002317536A CA2317536A1 (fr) 1998-01-14 1999-01-13 Derives aminosulphonylbenzamides utilises comme inhibiteurs de l'activite des canaux calcium neuronaux
AU21728/99A AU2172899A (en) 1998-01-14 1999-01-13 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels
EP99901722A EP1047670A1 (fr) 1998-01-14 1999-01-13 Derives aminosulphonylbenzamides utilises comme inhibiteurs de l'activite des canaux calcium neuronaux
PCT/GB1999/000099 WO1999036398A1 (fr) 1998-01-14 1999-01-13 Derives aminosulphonylbenzamides utilises comme inhibiteurs de l'activite des canaux calcium neuronaux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9800750.3A GB9800750D0 (en) 1998-01-14 1998-01-14 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
GB9800750D0 true GB9800750D0 (en) 1998-03-11

Family

ID=10825269

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9800750.3A Ceased GB9800750D0 (en) 1998-01-14 1998-01-14 Pharmaceutical compound

Country Status (6)

Country Link
EP (1) EP1047670A1 (fr)
JP (1) JP2002509135A (fr)
AU (1) AU2172899A (fr)
CA (1) CA2317536A1 (fr)
GB (1) GB9800750D0 (fr)
WO (1) WO1999036398A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812198B1 (fr) * 2000-07-28 2008-07-18 Sod Conseils Rech Applic DERIVES D'AMIDINES INHIBITEURS DE PHOSPHATASES cdc25
CA2461603A1 (fr) * 2001-09-24 2003-04-03 Elan Pharmaceuticals, Inc. Amines substituees pour le traitement de la maladie d'alzheimer
TW200302717A (en) * 2002-02-06 2003-08-16 Schering Corp Novel gamma secretase inhibitors
JP2006511587A (ja) 2002-12-20 2006-04-06 ミジェニックス コーポレイション アデニンヌクレオチドトランスロカーゼ(ant)リガンドならびにそれに関連する組成物および方法
CA2611731A1 (fr) * 2005-06-09 2006-12-14 Vertex Pharmaceuticals Incorporated Derives d'indane comme modulateurs de canaux ioniques
JP5361857B2 (ja) * 2007-03-23 2013-12-04 ファイザー・リミテッド イオンチャネルの阻害剤
GB201007791D0 (en) * 2010-05-10 2010-06-23 Glaxo Group Ltd Novel compounds
GB201007789D0 (en) * 2010-05-10 2010-06-23 Glaxo Group Ltd Novel Compound
EP2726459B1 (fr) * 2011-07-01 2019-09-11 Baruch S. Blumberg Institute Dérivés de sulfamoylbenzamide en tant qu'agents antiviraux contre une infection par vhb
JP7395480B2 (ja) 2018-01-10 2023-12-11 クラ セラピューティクス, エルエルシー フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用
US20220274921A1 (en) * 2019-07-11 2022-09-01 Cura Therapeutics, Llc Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications
EP4172149A4 (fr) * 2020-06-29 2024-09-04 Bacainn Biotherapeutics, Ltd. Composés de probénécide pour le traitement d'une maladie pulmonaire à médiation par inflammasomes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59305042D1 (de) * 1992-09-22 1997-02-20 Hoechst Ag Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika

Also Published As

Publication number Publication date
CA2317536A1 (fr) 1999-07-22
AU2172899A (en) 1999-08-02
JP2002509135A (ja) 2002-03-26
WO1999036398A1 (fr) 1999-07-22
EP1047670A1 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
GB9817118D0 (en) Pharmaceutical compounds
GB9817623D0 (en) Pharmaceutical compounds
CZ20011518A3 (cs) Farmaceutický prostředek
GB9810886D0 (en) Pharmaceutical compounds
GB9700504D0 (en) Pharmaceutical compounds
PT1466615E (pt) Composição farmacêutica
EG22250A (en) Novel pharmaceutical compound
PL343769A1 (en) Pharmaceutical composition
GB9812038D0 (en) Therapeutic compound
EP1145714A4 (fr) Medicaments
GB9818591D0 (en) Pharmaceutical composition
GB9716244D0 (en) Pharmaceutical compounds
EP1003495A4 (fr) Composes pharmaceutiques
IL145632A0 (en) Pharmaceutical compounds
GB9805348D0 (en) Compound
GB9800750D0 (en) Pharmaceutical compound
GB9916434D0 (en) Pharmaceutical compounds
GB9808268D0 (en) Compound
GB9914255D0 (en) Pharmaceutical compounds
GB9823847D0 (en) Pharmaceutical compounds
GB9823845D0 (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
AP2000001878A0 (en) Pharmaceutical compositions
GB9700895D0 (en) Pharmaceutical compounds
GB2373499B (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)